The CTRC, an NCI-designated cancer center and part of University of Texas Health Science Center at San Antonio, joins the Caris Centers of Excellence for Precision Medicine Network to help develop guidelines and standards of care for tumor profiling.
As a Network member, the CTRC will actively participate in the development of standards of care and best practices for integrating molecular profiling in oncology practice, while also striving to increase widespread adoption and patient access to personalized medicine in clinical settings. The CTRC will also leverage Caris’ multiple-technology tumor profiling service, Caris Molecular IntelligenceA®, to enable the practice of precision medicine by identifying therapy options and clinical trial opportunities based on the unique characteristics of a patient’s tumor.
“The patented and proprietary offering provided by Caris Life Sciences equips our physicians with the most up-to-date molecular data for our patients. In turn, this enhances therapy selection, clinical trial participation and furthers our understanding of the unique biological make up of patient tumors,” said Dr. Ian M. Thompson, Jr., director of the Cancer Therapy & Research Center said in a statement. “We are excited to join this Precision Medicine Network, where by collaborating with other large cancer care organizations, we can provide increasingly powerful and timely personalized information to aid physicians in making difficult therapy decisions.”